1996•Schizophrenia ResearchRequires access

Symptom dimensions in psychotic disorder and regional cerebral glucose metabolism using 18F-fluorodeoxyglucose and positron emission tomography

A.H. Al-Mousawi, N. Evans, Dirk Roeda, Fiona Chaloner, George P. Ashcroft

Open publisher page 0 citations

Abstract

This record does not include an abstract. Use the full-text link above if available.

About this research paper

What this paper is about

An abstract is not available in the OpenAlex record for this paper.

Why it matters

A significance statement is not available in the OpenAlex record.

Key contribution

A contribution statement is not available in the OpenAlex record.

Method / approach

Method details are not available in the OpenAlex metadata.

Main findings

Findings are not separately available in the OpenAlex metadata.

Limitations

Limitations are not available in the OpenAlex metadata.

Applications

Application details are not available in the OpenAlex metadata.

Key concepts: Positron emission tomography, Fluorodeoxyglucose, Positron, Nuclear medicine, Medicine, Brain positron emission tomography, Psychology, Preclinical imaging

Related papers

Back to paper searchBrowse research topicsOriginal source
Symptom dimensions in psychotic disorder and regional cerebral glucose metabolism using 18F-fluorodeoxyglucose and positron emission tomography — Research Paper | ScholarLens